PubMed HealthSearch

PubMed · 2234985

[Atopy: definition--pathogenesis].

Abstract

After a short historical review about the detection of reagins by Coca and Prausnitz-Küstner 1921-1923 and about their physico-chemical characterisation as IgE-antibodies by Ishizaka and Johansson 1967-1968 the definition and the clinical relevance of atopy is discussed. The IgE-regulation by interleukins and the pathomechanism of IgE-mediated allergies is reviewed. Of special importance is the IgE-mediated inflammatory late-reaction and the--therefore caused--unspecific hyperreactivity of the stricken tissue, both characteristic features of asthma bronchiale as well as atopic dermatitis.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

B Wüthrich. 1990. [Atopy: definition--pathogenesis].. https://pubmed.ncbi.nlm.nih.gov/2234985/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Single-cell transcriptome revealed the aberrant keratinocytes activation in antigen presentation in atopic dermatitis.

BACKGROUND: Atopic dermatitis (AD), a common chronic inflammatory skin disease, has been extensively studied using single-cell genomics. However, keratinocytes, as key effector cells in AD, have underlying mechanisms remain incompletely understood and require further investigation. METHODS: We integrated single-cell transcriptomic data from skin tissues of healthy controls, chronic active AD patients, spontaneously healed AD (SHAD) patients, and an ovalbumin-induced AD mouse model. The study particularly emphasized the gene expression and cellular dynamics of keratinocytes across the different groups, as well as their interactions with immune cells. RESULTS: Compared to healthy controls, we observed significant changes in the keratinocyte transcriptome, cellular state, and keratinocyte-immune cell ligand-receptor interactions in AD skin, particularly the marked activation of genes involved in antigen processing and presentation. Interestingly, such gene activation was not observed in keratinocytes from the ovalbumin-induced AD mouse model, despite its phenotype closely resembling human AD. Furthermore, in SHAD, we identified a recovery of both the ligand-receptor interaction patterns and antigen processing and presentation genes, accompanied by a notable shift in the transcriptome. This involved a significant downregulation of genes related to cytoplasmic transcription and oxidative phosphorylation. Notably, this pattern was not observed in the self-healing mouse model following the removal of ovalbumin stimulation. CONCLUSION: Our results suggest that the persistent activation of antigen processing and presentation pathways in keratinocytes may be a key driver of chronic inflammation in AD. Therefore, redirecting anti-allergic therapeutic strategies from solely targeting immune cells to targeting of keratinocyte-mediated antigen presentation may offer a more effective approach. Furthermore, we raise concerns about the use of ovalbumin-induced mouse models to recapitulate human chronic AD, as the underlying mechanisms may differ significantly.

Dermatitis, Atopic